India · Delayed Price · Currency is INR Theseus Pharmaceuticals Statistics
Total Valuation
NSE:HCLTECH has a market cap or net worth of INR 3.93 trillion. The enterprise value is 3.73 trillion.
| Market Cap | 3.93T |
| Enterprise Value | 3.73T |
Important Dates
The last earnings date was Friday, July 11, 2025.
| Earnings Date | Jul 11, 2025 |
| Ex-Dividend Date | Jul 18, 2025 |
Share Statistics
NSE:HCLTECH has 2.71 billion shares outstanding. The number of shares has decreased by -0.04% in one year.
| Current Share Class | 2.71B |
| Shares Outstanding | 2.71B |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | -0.08% |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 25.26% |
| Float | 1.05B |
Valuation Ratios
The trailing PE ratio is 23.00 and the forward PE ratio is 21.72. NSE:HCLTECH's PEG ratio is 2.67.
| PE Ratio | 23.00 |
| Forward PE | 21.72 |
| PS Ratio | 3.27 |
| PB Ratio | 5.62 |
| P/TBV Ratio | 9.56 |
| P/FCF Ratio | 18.95 |
| P/OCF Ratio | 17.84 |
| PEG Ratio | 2.67 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.55, with an EV/FCF ratio of 17.94.
| EV / Earnings | 21.77 |
| EV / Sales | 3.10 |
| EV / EBITDA | 14.55 |
| EV / EBIT | 17.14 |
| EV / FCF | 17.94 |
Financial Position
The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.26 |
| Quick Ratio | 2.06 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.26 |
| Debt / FCF | 0.32 |
| Interest Coverage | 32.91 |
Financial Efficiency
Return on equity (ROE) is 24.61% and return on invested capital (ROIC) is 17.95%.
| Return on Equity (ROE) | 24.61% |
| Return on Assets (ROA) | 13.25% |
| Return on Invested Capital (ROIC) | 17.95% |
| Return on Capital Employed (ROCE) | 27.93% |
| Revenue Per Employee | 5.45M |
| Profits Per Employee | 775,073 |
| Employee Count | 220,755 |
| Asset Turnover | 1.17 |
| Inventory Turnover | 494.76 |
Taxes
In the past 12 months, NSE:HCLTECH has paid 57.98 billion in taxes.
| Income Tax | 57.98B |
| Effective Tax Rate | 25.30% |
Stock Price Statistics
The stock price has decreased by -11.60% in the last 52 weeks. The beta is 0.39, so NSE:HCLTECH's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -11.60% |
| 50-Day Moving Average | 1,636.22 |
| 200-Day Moving Average | 1,707.34 |
| Relative Strength Index (RSI) | 20.70 |
| Average Volume (20 Days) | 3,898,647 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:HCLTECH had revenue of INR 1.20 trillion and earned 171.10 billion in profits. Earnings per share was 63.14.
| Revenue | 1.20T |
| Gross Profit | 417.50B |
| Operating Income | 217.33B |
| Pretax Income | 229.16B |
| Net Income | 171.10B |
| EBITDA | 247.69B |
| EBIT | 217.33B |
| Earnings Per Share (EPS) | 63.14 |
Balance Sheet
The company has 274.96 billion in cash and 65.61 billion in debt, giving a net cash position of 209.35 billion or 77.27 per share.
| Cash & Cash Equivalents | 274.96B |
| Total Debt | 65.61B |
| Net Cash | 209.35B |
| Net Cash Per Share | 77.27 |
| Equity (Book Value) | 699.67B |
| Book Value Per Share | 258.18 |
| Working Capital | 347.78B |
Cash Flow
In the last 12 months, operating cash flow was 220.50 billion and capital expenditures -12.86 billion, giving a free cash flow of 207.64 billion.
| Operating Cash Flow | 220.50B |
| Capital Expenditures | -12.86B |
| Free Cash Flow | 207.64B |
| FCF Per Share | 76.64 |
Margins
Gross margin is 34.72%, with operating and profit margins of 18.07% and 14.23%.
| Gross Margin | 34.72% |
| Operating Margin | 18.07% |
| Pretax Margin | 19.06% |
| Profit Margin | 14.23% |
| EBITDA Margin | 20.60% |
| EBIT Margin | 18.07% |
| FCF Margin | 17.27% |
Dividends & Yields
This stock pays an annual dividend of 54.00, which amounts to a dividend yield of 3.68%.
| Dividend Per Share | 54.00 |
| Dividend Yield | 3.68% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 95.59% |
| Buyback Yield | 0.04% |
| Shareholder Yield | 3.72% |
| Earnings Yield | 4.35% |
| FCF Yield | 5.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 5, 2019. It was a forward split with a ratio of 2.
| Last Split Date | Dec 5, 2019 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
NSE:HCLTECH has an Altman Z-Score of 11.02 and a Piotroski F-Score of 5.
| Altman Z-Score | 11.02 |
| Piotroski F-Score | 5 |